Objective: To define brain activity and behavioral changes in mild cognitive impairment (MCI), an isolated memory deficit in the elderly that is a major risk factor for Alzheimer's disease.
Introduction
Mild cognitive impairment (MCI) is a clinical condition that characterizes elderly individuals with an episodic memory impairment that is more severe than in normal aging, while other cognitive functions are relatively normal (Petersen et al., 1999; Ritchie and Touchon, 2000; reviewed in Collie and Maruff, 2000) . MCI has been shown to be an important risk factor for Alzheimer's disease (Smith et al., 1996; Petersen et al., 1999; Celsis, 2000) . The conversion rate (i.e. percentage of MCI patients who subsequently decline to meet the criteria for Alzheimer's disease) is estimated at about 12% per year, which is approximately a 6-fold increased risk of Alzheimer's disease as compared to elderly subjects without memory impairments (Petersen et al., 1999) . Neuropsychological testing also suggests that group differences with controls are greatest in tests of episodic memory, with lesser declines or no significant group differences in other tests (Berent et al., 1999; Petersen et al., 1999 ).
Alzheimer's disease has a long preclinical period, lasting years to decades, when b-amyloid plaques and neurofibrillary tangles accumulate in the brain without appreciable clinical abnormalities (Morrison and Hof, 1997; Celsis, 2000; Elias et al., 2000; Small et al., 2000) . The long preclinical period of Alzheimer's disease coupled with the observation that many MCI patients convert to Alzheimer's disease within a few years implies that many MCI patients have neuropathology similar to Alzheimer's disease. Consistent with this notion, Price and Morris, 1999 described extensive b-amyloid plaques in both nondemented and mildly demented subjects. A recent study also reported that MCI subjects had neuropathological findings characteristic of Alzheimer's disease (Morris et al., 2001) .
The neurobiological changes associated with MCI, and their significance for psychological functioning, are poorly understood. To address this issue a target detection task was employed that has previously been shown to reveal abnormalities in brain activity, measured via event-related potentials, and reaction time in subjects with Alzheimer's disease
